Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Integrum

9.20 SEK+3.95 %11/9 17:25
Less than 1K followers

INTEG B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
+3.95 %
+9.00 %
+13.86 %
+9.92 %
-14.50 %
-78.23 %
-58.50 %
-90.57 %
-53.83 %

Integrum is active in medical technology. The company develops systems for skeletally anchored prostheses based on the developed OPRA implant system, which is later resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of a large number of patients with amputation. The company was founded in 1998 and has its headquarters in Mölndal.

Read more
Market cap
245.34M SEK
Turnover
283.95K SEK
Revenue
91.38M
EBIT %
-58.17 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
3/12
2026

Interim report Q2'27

4/3
2027

Interim report Q3'27

10/6
2027

Annual report '27

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-09-12 22:40

Integrum publicerar årsredovisning 2025/26

Integrum
Regulatory press release2026-09-12 22:40

Integrum publishes Annual Report 2025/26

Integrum
Regulatory press release2026-09-08 16:00

Integrum välkomnar det ukrainska ministerkabinettets beslut att införa ett statsfinansierat pilotprogram för osseointegration

Integrum

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-09-08 16:00

Integrum welcomes the Ukrainian Cabinet of Ministers’ decision to introduce a state-funded pilot program for osseointegration

Integrum
Regulatory press release2026-09-03 07:15

Integrum publicerar delårsrapport för första kvartalet 2026/27

Integrum
Regulatory press release2026-09-03 07:15

Integrum publishes interim report for the first quarter of 2026/27

Integrum
Regulatory press release2026-08-31 19:00

Integrum bjuder in till presentation av Q1 2026/27

Integrum
Regulatory press release2026-08-31 19:00

Integrum invites to presentation of Q1 2026/27 results

Integrum
Regulatory press release2026-08-27 15:15

Kallelse till årsstämma i Integrum AB

Integrum
Regulatory press release2026-08-03 10:00

Valberedning utsedd i Integrum AB (publ) inför årsstämman 2026

Integrum
Regulatory press release2026-08-03 10:00

Nomination Committee appointed in Integrum AB (publ) ahead of the 2026 Annual General Meeting

Integrum
Regulatory press release2026-07-28 14:55

Integrum erhåller ytterligare återbetalning av tullavgifter om cirka 3,3 MSEK

Integrum
Regulatory press release2026-07-28 14:55

Integrum receives additional custom duty refund of approximately SEK 3.3 million

Integrum
Regulatory press release2026-06-29 08:30

Ukrainas hälsoministerium lämnar över förslag till regeringen om utökad användning av osseointegration i sjukvården

Integrum
Regulatory press release2026-06-29 08:30

Ukraine's Ministry of Health submits proposal to the government on expanded use of osseointegration in healthcare

Integrum
Regulatory press release2026-06-16 15:23

Integrum erhåller återbetalning av tullavgifter om cirka 2,6 MSEK

Integrum
Regulatory press release2026-06-16 15:23

Integrum receives customs duty refund of approximately SEK 2.6 million

Integrum
Regulatory press release2026-06-09 09:15

Integrum avser att bolagisera all verksamhet inom bionik under namnet Afyri

Integrum
Regulatory press release2026-06-09 09:15

Integrum intends to incorporate all operations within bionics under the name Afyri

Integrum
Regulatory press release2026-06-04 07:15

BOKSLUTSKOMMUNIKÉ 2025/2026

Integrum